During the past 12 months, Asymchem Laboratories Tianjin Co's average EBITDA Per Share Growth Rate was 10.70% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was -22.60% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 8.10% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 21.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Asymchem Laboratories Tianjin Co was 68.80% per year. The lowest was -22.60% per year. And the median was 26.40% per year.
Asymchem Laboratories Tianjin Co (OTCPK:ASLTY) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Asymchem Laboratories Tianjin Co 3-Year EBITDA Growth Rate Related Terms
ASLTY vs VRTX, REGN, ALNY: 3-Year EBITDA Growth Rate Comparison
For the Biotechnology subindustry, Asymchem Laboratories Tianjin Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Asymchem Laboratories Tianjin Co 3-Year EBITDA Growth Rate vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Asymchem Laboratories Tianjin Co's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Asymchem Laboratories Tianjin Co's 3-Year EBITDA Growth Rate falls into.
Asymchem Laboratories Tianjin Co 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of -22.60% mean?
Asymchem Laboratories Tianjin Co (ASLTY) has a 3-Year EBITDA Growth Rate of -22.60% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Asymchem Laboratories Tianjin Co and its competitors. According to the industry distribution chart, Asymchem Laboratories Tianjin Co ranks #987 out of 1136 companies in the Biotechnology industry, placing it in the top 86.9%.
Is Asymchem Laboratories Tianjin Co's 3-Year EBITDA Growth Rate too high?
Asymchem Laboratories Tianjin Co's current 3-Year EBITDA Growth Rate is -22.60%. Based on the distribution chart, Asymchem Laboratories Tianjin Co ranks #987 out of 1136 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Asymchem Laboratories Tianjin Co has a GF Score™ of 72/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Asymchem Laboratories Tianjin Co's 3-Year EBITDA Growth Rate compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Asymchem Laboratories Tianjin Co ranks #987 out of 1136 companies for 3-Year EBITDA Growth Rate. This places Asymchem Laboratories Tianjin Co in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 14.85. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Biotechnology company?
The median 3-Year EBITDA Growth Rate among Biotechnology companies is 14.85, based on 1,136 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Asymchem Laboratories Tianjin Co and its competitors. For the Biotechnology industry, the median 3-Year EBITDA Growth Rate is 14.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Asymchem Laboratories Tianjin Co's current 3-Year EBITDA Growth Rate is -22.60%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asymchem Laboratories Tianjin Co stock overvalued right now?
Based on GuruFocus' analysis, Asymchem Laboratories Tianjin Co (ASLTY) is currently considered Significantly Overvalued. The stock's GF Value™ is $4.65, compared to a current price of $6.37 — trading 37% above its estimated fair value. The current 3-Year EBITDA Growth Rate is -22.60%. Asymchem Laboratories Tianjin Co's overall GF Score™ is 72/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Asymchem Laboratories Tianjin Co (ASLTY), the current 3-Year EBITDA Growth Rate is -22.60% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Asymchem Laboratories Tianjin Co (ASLTY) Overvalued in 2026?
Based on GuruFocus' analysis, Asymchem Laboratories Tianjin Co stock appears to be overvalued.
The current stock price of $6.37 is trading 37% above its estimated GF Value™ of $4.65.
GuruFocus considers Asymchem Laboratories Tianjin Co to be Significantly Overvalued.
Key valuation signals for ASLTY:
3-Year EBITDA Growth Rate: -22.60%
GF Value™: $4.65 vs. price of $6.37 (37% above fair value)
No single metric tells the full story. See the ASLTY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Asymchem Laboratories Tianjin Co Business Description
Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development and manufacturing organization solutions throughout the drug development and manufacturing process. The group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing, which focus on innovation and commercial application of pharmaceutical technology. It has geographic areas in the Chinese Mainland and Overseas.
72GF Score
Get the complete analysis for ASLTY
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASLTY has been successfully added to your 